EdemSAgamahMD

Oncology • Springfield, IL

Central Illinois Hematology Oncology Center

Join to view full profile

Dr. Agamah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Agamah's full profile

Already have an account?

Office
315 W Carpeneter St
P.O. Box 19678
Springfield, IL 62794
Phone+1 217-545-8000

Fax+1 217-545-7021
Is this information wrong?

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 1993 - 1995
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1990 - 1993
University of Ghana Medical SchoolClass of 1985

Certifications & Licensure

IL State Medical License 1992 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 2001

Clinical Trials

Decitabine in Treating Patients With Myelofibrosis Start of enrollment: 2004 Sep 29
Active, not recruiting
Phase 2
Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
Active, not recruiting
Phase 1, Phase 2
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Start of enrollment: 2008 Jun 01
Completed
Phase 1
IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery Start of enrollment: 2008 Dec 01
Terminated
Phase 2
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Completed
Phase 2
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery Start of enrollment: 2009 Sep 01
Completed
Phase 2
Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer Start of enrollment: 2009 Aug 01
Completed
Phase 1
Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer Start of enrollment: 2009 Sep 01
Completed
Phase 1, Phase 2
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma Start of enrollment: 2010 Apr 15
Completed
Phase 1, Phase 2
Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery Start of enrollment: 2010 Oct 01
Terminated
Phase 2
MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy Start of enrollment: 2010 Dec 01
Terminated
Phase 2
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy Start of enrollment: 2010 Nov 01
Completed
Phase 2
Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel Start of enrollment: 2010 Oct 01
Completed
Phase 2
Saracatinib in Treating Patients With Prostate Cancer Start of enrollment: 2010 Dec 01
Terminated
Phase 2
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Erratum to: The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Meta...
Lerario, A. M.,Worden, F. P.,Ramm, C. A.,Hesseltine, E. A.,Stadler, W. M.,Else, T.,Shah, M. H.,Agamah, E.,Rao, K.,Hammer, G. D.> ;Horm Cancer. 2014 Sep 07
70 citations
The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adren...
Antonio M. Lerario, Francis P. Worden, Carole A. Ramm, Elizabeth Hesseltine, Walter M. Stadler, Tobias Else, Manisha H. Shah, Edem Agamah, Krishna Rao, Gary D. Hammer> ;Hormones & Cancer. 2014 May 22
45 citations
Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Nicholas P. Campbell, Rangesh Kunnavakkam, Natasha B. Leighl, Mark Vincent, David R. Gandara, Marianna Koczywas, Barbara J. Gitlitz, Edem Agamah, Sachdev P. Thomas, Wa...> ;Lung Cancer. 2012 Oct 1
75 citations
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium
Hedy L. Kindler, Kristen Wroblewski, James A. Wallace, Michael J. Hall, Gershon Y. Locker, Sreenivasa Nattam, Edem Agamah, Walter M. Stadler, Everett E. Vokes> ;Investigational New Drugs. 2012 Feb 1
Cediranib (C) in patients (pts) with malignant mesothelioma (MM): A phase II trial of The University of Chicago Phase II Consortium.
Campbell NP, Kunnavakkam R, Leighl NB, Vincent MD, Gandara DR, Koczywas M, Gitlitz BJ, Agamah ES, Thomas SP, Stadler WM, Vokes EE, Kindler HL> ;J. Clin. Oncol.. 2011-05-20
64 citations
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia
Halla S. Nimeiri, Amit M. Oza, Robert J. Morgan, Dezheng Huo, Laurie Elit, James A. Knost, James L. Wade, Edem Agamah, Everett E. Vokes, Gini F. Fleming> ;Gynecologic Oncology. 2010 Apr 1
Sorafenib (SOR) in patients (pts) with advanced/recurrent uterine carcinoma (UCA) or carcinosarcoma (CS): A phase II trial of the University of Chicago, PMH, and Calif...
Nimeiri HS, Oza AM, Morgan RJ, Huo D, Elit L, Knost J, Wade Iii JL, Agamah E, Vokes EE, Fleming GF> ;J. Clin. Oncol.. 2008-05-20
Activity of sorafenib (SOR) in patients (pts) with imatinib (IM) and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST): A phase II trial of the Uni...
Wiebe L, Kasza KE, Maki RG, D'Adamo DR, Chow WA, Wade Iii JL, Agamah E, Stadler WM, Vokes EE, Kindler HL> ;J. Clin. Oncol.. 2008-05-20
A phase II trial of the epothilone B analog BMS-247550 in patients (pts) with hepatobiliary cancer (HBC): An updated analysis.
Singh DA, Taber D, Ansari R, Lenz HJ, Agamah E, Nattam S, Wade-Oliver K, Kasza K, Vokes EE, Kindler HL> ;J. Clin. Oncol.. 2006-06-20
30 citations
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
Christopher W. Ryan, M. Eileen Dolan, Bruce Brockstein, Roger E. McLendon, Shannon M. Delaney, Brian L. Samuels, Edem Agamah, Everett E. Vokes> ;Cancer Chemotherapy and Pharmacology. 2006 Mar 7
13 citations
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
Apurva A. Desai, Hedy L. Kindler, David A. Taber, Edem Agamah, Sridhar Mani, Kurombi Wade-Oliver, Mark J. Ratain, Everett E. Vokes> ;Cancer Chemotherapy and Pharmacology. 2005 May 13
16 citations
Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium
Termkiat Kanchanapoom, Janak Koirala, James Goodrich, Edem Agamah, Nancy Khardori> ;Diagnostic Microbiology and Infectious Disease. 2003 Mar 1
Serum creatinine and its relation to cardiovascular disease risk variables in children and young adults from a biracial community. The Bogalusa Heart Study.
Agamah, E. S., Webber, L. S., Lawrence, M., Wattigney, W., Berenson, G. S.> ;J Lab Clin Med. 1990 Sep
Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study.
Agamah, E. S., Srinivasan, S. R., Webber, L. S., Berenson, G. S.> ;J Lab Clin Med. 1991 Sep
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Physicians - ACP
Fellow

Hospital Affiliations

Springfield Memorial HospitalSpringfield, Illinois
HSHS St. John's HospitalSpringfield, Illinois
Jacksonville Memorial HospitalJacksonville, Illinois
HSHS St. Francis HospitalLitchfield, Illinois

EdemSAgamahMD

Dr. Agamah is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.